14 results
8-K
EX-10.1
TYRA
Tyra Biosciences Inc
5 Feb 24
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
6:05am
or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances), and all
S-3
EX-1.2
TYRA
Tyra Biosciences Inc
3 Oct 22
Shelf registration
4:05pm
to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products
10-K
2021 FY
EX-10.15
TYRA
Tyra Biosciences Inc
3 Mar 22
Annual report
4:31pm
does not contain hazardous levels of any mold or fungi defined as toxic under applicable state or federal law. If a non-compliance with such warranty
10-K
2021 FY
TYRA
Tyra Biosciences Inc
3 Mar 22
Annual report
4:31pm
against potential liabilities. We do not maintain insurance for toxic tort claims that may be asserted against us in connection with our storage
10-Q
394exm9yny
3 Nov 21
Quarterly report
4:31pm
424B4
jnydvaejb3sm0gb4zquf
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
7nxdc83
9 Sep 21
IPO registration (amended)
6:08am
S-1/A
EX-1.1
hngx0t pcw7
9 Sep 21
IPO registration (amended)
6:08am
S-1
o8rek
20 Aug 21
IPO registration
4:07pm
S-1
EX-10.19
dine5ch308bn
20 Aug 21
IPO registration
4:07pm
DRS/A
z0htj8cs
2 Jul 21
Draft registration statement (amended)
12:00am
DRS
1f6v ksgj7y0ytuvs5p
28 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next